Starting doses begin at 2.5 mg weekly (an initiation dose not intended for glycaemic control), with gradual titration up to a maintenance dose of 5 mg, 10 mg, or 15 mg, depending on individual response and tolerability
GLP-1 receptor agonists still suppress alpha-cell function even if beta-cell function is already impaired and can bring glucagon levels down to normal levels seen in healthy individuals 6
Energy Expenditure and Metabolic Rate Research Retatrutide's tri-agonist profile also makes it relevant for research involving energy expenditure and metabolic rate
Avoid exposure to excessive heat, moisture, and direct sunlight
Individual yeast colonies were randomly picked from the plates, and small-scale expression experiments were performed according to the manufacturers instructions (Invitrogen)
With the rising popularity of GLP-1 receptor agonists and the future shortages for many of these drugs, it comes as no surprise to see counterfeit products entering the market